A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples